Albert Sjoerdsma
About
In The Last Decade
Albert Sjoerdsma
260 papers receiving 13.7k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Molecular Biology 5.8k
- Cellular and Molecular Neuroscience 3.1k
- Epidemiology 2.3k
- Physiology 2.2k
- Biochemistry 2.1k
Countries citing papers authored by Albert Sjoerdsma
This map shows the geographic impact of Albert Sjoerdsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Sjoerdsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Sjoerdsma more than expected).
Fields of papers citing papers by Albert Sjoerdsma
This network shows the impact of papers produced by Albert Sjoerdsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Sjoerdsma. The network helps show where Albert Sjoerdsma may publish in the future.
Co-authorship network of co-authors of Albert Sjoerdsma
This figure shows the co-authorship network connecting the top 25 collaborators of Albert Sjoerdsma. A scholar is included among the top collaborators of Albert Sjoerdsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Sjoerdsma. Albert Sjoerdsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 47 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 101 | |
| 6 | 26 | |
| 7 | 17 | |
| 8 | 197 | |
| 9 | 5 | |
| 10 | Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. | 63 |
| 11 | 18 | |
| 12 | 59 | |
| 13 | Catecholamines in hypertension. | 1 |
| 14 | 30 | |
| 15 | 33 | |
| 16 | 22 | |
| 17 | 47 | |
| 18 | 127 | |
| 19 | 14 | |
| 20 | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.